Does SUMATRIPTAN Cause Injection site swelling? 49 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Injection site swelling have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.3% of all adverse event reports for SUMATRIPTAN.
49
Reports of Injection site swelling with SUMATRIPTAN
0.3%
of all SUMATRIPTAN reports
0
Deaths
13
Hospitalizations
How Dangerous Is Injection site swelling From SUMATRIPTAN?
Of the 49 reports, 13 (26.5%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which SUMATRIPTAN Alternatives Have Lower Injection site swelling Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT